This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.

What resistance means

HIV can change as it reproduces. Some changes make particular antiretroviral medicines less effective; this is drug resistance. A resistant strain can also be transmitted. Resistance is a property of the virus, not a judgment about the person living with it.

Resistance does not mean that every HIV medicine has stopped working. Which medicines may be affected depends on the specific viral changes and treatment history. A clinician interprets that information when selecting a regimen.

Sources for this section: [1][3]

How resistance can arise

When HIV is not fully controlled, it can continue to reproduce and acquire changes. Difficulty taking or obtaining treatment can contribute, but it is not the only factor a clinician considers. Drug interactions or insufficient medicine exposure can also affect response.

A detectable viral load does not by itself prove resistance. Your team may review earlier results, medicine use and interactions, and decide whether further testing is useful. The goal is to identify a workable treatment, not assign blame.

Sources for this section: [1][2]

What testing contributes

Resistance testing can help identify changes relevant to treatment choice. A clinician considers when the sample was collected, the current regimen and prior results. A test result is not a complete replacement for the treatment history.

If testing is discussed, ask what it can answer, when the result is expected and whether the timing of your medicines affects its usefulness. Do not change or stop treatment in preparation unless the treating team gives you specific instructions.

Sources for this section: [3][2]

Keep a treatment history

Save copies of resistance reports and treatment lists if possible. Include earlier HIV medicines, dates when known and any PrEP or PEP use. Old pharmacy records or medicine bottles can help fill gaps; it is fine to say that you do not remember.

Share the history when changing clinicians or discussing a new regimen. Previous results can remain relevant even if a later report does not repeat every earlier finding.

Sources for this section: [3]

Questions about the next step

Ask which medicines are affected, which options are being considered and whether the team needs additional information. If treatment changes, ask how the transition will work and when viral load will be checked afterward.

An unexpected result can be upsetting, but it is a reason for a concrete plan rather than a reason to give up on care. Ask for the name of a contact who can explain the results and help if the new plan is difficult to follow.

Sources for this section: [3][2]

Why an older result can still matter

A resistance test reflects the virus detected in a particular sample at a particular time. NIH guidance explains that resistant virus can remain in the body even when a later test does not show the earlier change. For that reason, clinicians consider the cumulative history rather than relying only on the newest report.

If you have changed clinics, ask how to transfer prior resistance reports and treatment records. Tell the team about treatment gaps and the last medicines used. You do not have to interpret mutations yourself; ask which findings influence the options being discussed and what uncertainty remains.

Sources for this section: [3][2][4]

Why the timing of a resistance test matters

NIH guidance generally recommends resistance testing for a failing non-long-acting regimen while the person is still taking it, or within four weeks after stopping if that is not possible. Testing later can still help but may miss resistance that was selected earlier. Different considerations apply after long-acting treatment.

This is a reason to contact the care team promptly, not an instruction to restart or stop medicine yourself. Tell the team the regimen and dates as accurately as you can, including injections. Ask whether a test is useful now and whether prior results should be obtained to complete the picture.

Sources for this section: [4][5]

Check the source

Sources & editorial note

We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.

  1. Treating HIV CDC. Accessed .
  2. Plasma HIV-1 RNA and CD4 Count Monitoring NIH ClinicalInfo. Accessed .
  3. Treatment Goals NIH ClinicalInfo. Accessed .
  4. Optimizing Antiretroviral Therapy in the Setting of Viral Suppression NIH ClinicalInfo. Accessed .
  5. Drug-Resistance Testing NIH ClinicalInfo. Accessed .

Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information